Dynamic T1-weighted ferumoxides enhanced MRI for imaging liver hemangiomas: Preliminary observations

Abdominal Imaging

Volumn 26, Issue 2, 2001, Pages 166-170

  Sahani, D ^a   Saini, S ^a   Sharma, R ^a   O'Malley, M ^a   Hahn, P ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Ferumoxides; Liver hemangiomas; MRI

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ARTICLE; CASE REPORT; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ELECTRON SPIN RESONANCE; HUMAN; IMAGE ANALYSIS; IMAGE ENHANCEMENT; LIVER HEMANGIOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SIDE EFFECT;

AGED; CONTRAST MEDIA; FEMALE; HEMANGIOMA; HUMANS; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES;

EID: 0035112361     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002610000123     Document Type: Article

References (21)

1. Iron oxide enhanced imaging of the liver and spleen, review of first 5 years
2. Contrast-enhanced MR imaging of the liver
3. Liver-specific MR imaging contrast agents
4. Detection of hepatic metastases: Ferumoxides-enhanced MR imaging versus unenhanced MR imaging and CT during arterial portography
5. Hepatic lesion detection: Comparison of MR imaging after administration of superparamagnetic iron oxide with dual -phase CT by using alternative-free response receiver operating characteristic analysis
6. Liver MR imaging with iron oxides: Towards consensus and clinical practice
7. Signal loss induced by superparamagnetic iron oxide particles in NMR spin-echo images; role of diffusion
8. Dual contrast enhancement of both T1- and T2-weighted sequences using ultrasmall superparamagnetic iron oxide
9. Superparamagnetic iron oxide as positive contrast agents: In vitro and in vivo evidence
10. T1 effects of a bolus-injectable superparamagnetic iron oxide. SH U 555A: Dependence on field strength and plasma concentration - Preliminary clinical experience with dynamic T1-weighted MR imaging
11. Enhancement of liver hemangiomas on T1-weighted MR SE images by superparamagnetic iron oxide particles
12. Hepatic lesions: Detection with ferumoxides-enhanced T1-weighted MR imaging
13. Superparamagnetic iron oxide: Pharmacokinetics and toxicity
14. Hepatic MR imaging with ferumoxides: A multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions
15. The effects of iron oxide on proton relaxivity
16. Physical and chemical properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxil
17. Surface properties of superparamagnetic iron oxide MR contrast agents: Ferumoxides, ferumoxtran, ferumoxil
18. Superparamagnetic iron oxide enhanced versus gadolinium-enhanced MR imaging for differential diagnosis of focal liver lesions
19. Benign hepatic tumors and tumor-like conditions in men
20. Clinical application of superparamagnetic iron oxide to MR imaging of tissue perfusion in vascular liver tumors
21. Differentiation of liver hemangiomas from metastases and hepatocellular carcinoma at MR imaging enhanced with blood-pool contrast agent Code-7227